rs748937055

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BS2_Supporting

The NM_004006.3(DMD):​c.8053G>A​(p.Glu2685Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000348 in 1,207,464 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 9 hemizygotes in GnomAD. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. E2685E) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000063 ( 0 hom., 2 hem., cov: 23)
Exomes 𝑓: 0.000032 ( 0 hom. 7 hem. )

Consequence

DMD
NM_004006.3 missense

Scores

4
5
7

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:7B:1

Conservation

PhyloP100: 7.90

Publications

0 publications found
Variant links:
Genes affected
DMD (HGNC:2928): (dystrophin) This gene spans a genomic range of greater than 2 Mb and encodes a large protein containing an N-terminal actin-binding domain and multiple spectrin repeats. The encoded protein forms a component of the dystrophin-glycoprotein complex (DGC), which bridges the inner cytoskeleton and the extracellular matrix. Deletions, duplications, and point mutations at this gene locus may cause Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), or cardiomyopathy. Alternative promoter usage and alternative splicing result in numerous distinct transcript variants and protein isoforms for this gene. [provided by RefSeq, Dec 2016]
DMD Gene-Disease associations (from GenCC):
  • Becker muscular dystrophy
    Inheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
  • dilated cardiomyopathy 3B
    Inheritance: XL Classification: DEFINITIVE Submitted by: Ambry Genetics
  • Duchenne and Becker muscular dystrophy
    Inheritance: XL Classification: DEFINITIVE Submitted by: Myriad Women’s Health
  • Duchenne muscular dystrophy
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • progressive muscular dystrophy
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • symptomatic form of muscular dystrophy of Duchenne and Becker in female carriers
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

BS2
High AC in GnomAd4 at 7 XL,AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DMDNM_004006.3 linkc.8053G>A p.Glu2685Lys missense_variant Exon 55 of 79 ENST00000357033.9 NP_003997.2 P11532

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DMDENST00000357033.9 linkc.8053G>A p.Glu2685Lys missense_variant Exon 55 of 79 1 NM_004006.3 ENSP00000354923.3 A0A075B6G3

Frequencies

GnomAD3 genomes
AF:
0.0000629
AC:
7
AN:
111228
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000967
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000113
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000168
AC:
3
AN:
178205
AF XY:
0.0000159
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000380
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000319
AC:
35
AN:
1096236
Hom.:
0
Cov.:
30
AF XY:
0.0000194
AC XY:
7
AN XY:
361736
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26377
American (AMR)
AF:
0.00
AC:
0
AN:
35075
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19352
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30116
South Asian (SAS)
AF:
0.00
AC:
0
AN:
53672
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40384
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4133
European-Non Finnish (NFE)
AF:
0.0000416
AC:
35
AN:
841111
Other (OTH)
AF:
0.00
AC:
0
AN:
46016
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.455
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000629
AC:
7
AN:
111228
Hom.:
0
Cov.:
23
AF XY:
0.0000598
AC XY:
2
AN XY:
33432
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30515
American (AMR)
AF:
0.0000967
AC:
1
AN:
10340
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2641
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3536
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2657
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5975
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
237
European-Non Finnish (NFE)
AF:
0.000113
AC:
6
AN:
53139
Other (OTH)
AF:
0.00
AC:
0
AN:
1504
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000434
Hom.:
0
Bravo
AF:
0.0000416
ExAC
AF:
0.0000165
AC:
2

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:7Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2
Jun 22, 2019
Revvity Omics, Revvity
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

The DMD p.Glu1341Lys variant was not identified in the literature nor was it identified in LOVD 3.0. The variant was identified in dbSNP (ID: rs748937055) and ClinVar (classified as a VUS by Invitae and Ambry Genetics). The variant was also identified in control databases in 3 of 178205 chromosomes (1 hemizygous) at a frequency of 0.000017 (Genome Aggregation Database March 6, 2019, v2.1.1) and was observed in the European (non-Finnish) population in 3 of 78996 chromosomes (freq: 0.00002704), but was not observed in the African, Latino, Ashkenazi Jewish, East Asian, European (Finnish), Other or South Asian populations. The p.Glu1341 residue is conserved in mammals but not in more distantly related organisms however four out of five computational analyses (SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. -

not specified Uncertain:1
Jun 14, 2019
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The DMD c.8053G>A; p.Glu2685Lys variant (rs748937055), to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 518815). This variant is found on only three chromosomes (3/178205 alleles, including one hemizygote) in the Genome Aggregation Database. The glutamate at codon 2685 is highly conserved and computational analyses (SIFT, PolyPhen-2) predict that this variant is deleterious. However, due to limited information, the clinical significance of the p.Glu2685Lys variant is uncertain at this time. -

Duchenne muscular dystrophy;C0878544:Cardiomyopathy;C0917713:Becker muscular dystrophy;na:Dystrophin deficiency Uncertain:1
Aug 31, 2018
Natera, Inc.
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Conduction disorder of the heart Uncertain:1
Oct 22, 2019
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Duchenne muscular dystrophy;C0917713:Becker muscular dystrophy;C3668940:Dilated cardiomyopathy 3B Uncertain:1
Sep 01, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Uncertain:1
Nov 10, 2020
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.E2685K variant (also known as c.8053G>A), located in coding exon 55 of the DMD gene, results from a G to A substitution at nucleotide position 8053. The glutamic acid at codon 2685 is replaced by lysine, an amino acid with similar properties. Based on data from gnomAD, the A allele has an overall frequency of <0.01% (3/178205) total alleles studied, with 1 hemizygote observed. The highest observed frequency was <0.01% (3/78996) of European (non-Finnish) alleles. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Duchenne muscular dystrophy Benign:1
Jan 20, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Pathogenic
0.27
D
BayesDel_noAF
Pathogenic
0.26
CADD
Pathogenic
26
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.30
.;T;T;.;.;T;.;.;T
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.92
D;.;.;.;D;.;D;D;.
M_CAP
Uncertain
0.16
D
MetaRNN
Uncertain
0.68
D;D;D;D;D;D;D;D;D
MetaSVM
Benign
-0.31
T
PhyloP100
7.9
PrimateAI
Uncertain
0.58
T
PROVEAN
Benign
-1.9
N;N;N;N;.;N;.;N;N
REVEL
Uncertain
0.40
Sift
Benign
0.090
T;T;T;T;.;D;.;D;T
Sift4G
Benign
0.13
T;T;T;T;D;D;D;D;T
Polyphen
0.87, 0.031, 0.85, 1.0
.;P;B;P;.;D;.;.;P
Vest4
0.82, 0.84, 0.85, 0.87, 0.83, 0.75, 0.80, 0.82
MutPred
0.57
.;.;.;.;.;.;.;Gain of MoRF binding (P = 0.012);.;
MVP
0.89
MPC
0.044
ClinPred
0.59
D
GERP RS
5.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
gMVP
0.64
Mutation Taster
=74/26
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs748937055; hg19: chrX-31645954; API